Dr. med. Harald Merckens


Summary of Multicenter Open Labeled Clinical Study in Advanced Breast Cancer Patients
In an open multicenter study(1) involving 9 oncological centers in Egypt, the effect of Viscum fraxini 2®(2) was investigated in 26 breast cancer patients with advanced illness. The study was conducted by Mahfouz et al. in collaboration with H. Werner, A. Scheffler of the Carl Gustav Carus Institut and I. Abouleu√≠sh of Atos Pharmaceuticals (Sekem), Cairo.


Dynamic Content Management by ContentTrakker